CN1043766C - 吲哚衍生物及其制法和它们在制备药物中的应用 - Google Patents

吲哚衍生物及其制法和它们在制备药物中的应用 Download PDF

Info

Publication number
CN1043766C
CN1043766C CN93114196A CN93114196A CN1043766C CN 1043766 C CN1043766 C CN 1043766C CN 93114196 A CN93114196 A CN 93114196A CN 93114196 A CN93114196 A CN 93114196A CN 1043766 C CN1043766 C CN 1043766C
Authority
CN
China
Prior art keywords
epoxy
indoles
beta
didehydro
oxymorphines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN93114196A
Other languages
English (en)
Chinese (zh)
Other versions
CN1092425A (zh
Inventor
长濑博
水砂明
河合孝治
中谷泉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Publication of CN1092425A publication Critical patent/CN1092425A/zh
Application granted granted Critical
Publication of CN1043766C publication Critical patent/CN1043766C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
CN93114196A 1992-09-29 1993-09-29 吲哚衍生物及其制法和它们在制备药物中的应用 Expired - Fee Related CN1043766C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP259841/92 1992-09-29
JP25984192 1992-09-29

Publications (2)

Publication Number Publication Date
CN1092425A CN1092425A (zh) 1994-09-21
CN1043766C true CN1043766C (zh) 1999-06-23

Family

ID=17339733

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93114196A Expired - Fee Related CN1043766C (zh) 1992-09-29 1993-09-29 吲哚衍生物及其制法和它们在制备药物中的应用

Country Status (14)

Country Link
US (2) US6087369A (https=)
EP (1) EP0614898B1 (https=)
JP (1) JP3605825B2 (https=)
KR (1) KR100301093B1 (https=)
CN (1) CN1043766C (https=)
AT (1) ATE239732T1 (https=)
AU (1) AU672033B2 (https=)
CA (1) CA2124455C (https=)
DE (1) DE69332945T2 (https=)
ES (1) ES2199220T3 (https=)
FI (1) FI942499A7 (https=)
NO (1) NO941977L (https=)
TW (1) TW271440B (https=)
WO (1) WO1994007896A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1043766C (zh) 1992-09-29 1999-06-23 东丽株式会社 吲哚衍生物及其制法和它们在制备药物中的应用
US5464841A (en) * 1993-11-08 1995-11-07 Univ Minnesota Use of delta opioid receptor antagonists to treat immunoregulatory disorders
SE9401727D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds I
SE9401728D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds II
US5578725A (en) * 1995-01-30 1996-11-26 Regents Of The University Of Minnesota Delta opioid receptor antagonists
US5849731A (en) * 1995-09-26 1998-12-15 Toray Industries, Inc. Indole derivatives and medical application thereof
US5994327A (en) * 1995-11-17 1999-11-30 Astra Ab Process for the preparation of morphinans
ATE229958T1 (de) * 1996-01-10 2003-01-15 Glaxosmithkline Spa Heterocyclische kondensierte morphin-derivate
ES2217533T3 (es) * 1997-01-16 2004-11-01 Toray Industries, Inc. Derivados de indolomorfinano y medicamentos/preventivos para transtornos cerebrales.
DE69839508D1 (de) 1997-03-31 2008-07-03 Toray Industries Chinolinmorphinan-derivate und ihre medizinische anwendung
US5986141A (en) * 1998-09-29 1999-11-16 Eastman Chemical Company Process for the production of cyclopropanemethylamine
CN1204139C (zh) * 1999-08-24 2005-06-01 东丽株式会社 神经性疼痛治疗剂
US8205237B2 (en) 2000-09-14 2012-06-19 Cox Ingemar J Identifying works, using a sub-linear time search, such as an approximate nearest neighbor search, for initiating a work-based action, such as an action on the internet
US7232829B2 (en) 2001-04-06 2007-06-19 Regents Of The University Of Minnesota Therapeutic compounds and methods
ATE422887T1 (de) 2001-05-04 2009-03-15 Amgen Inc Kondensierte heterozyklische verbindungen
US6809104B2 (en) 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
JP2005530685A (ja) * 2002-01-25 2005-10-13 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 選択的鎮痛剤
US7253179B2 (en) 2002-11-06 2007-08-07 Amgen Inc. Fused heterocyclic compounds
EP1595541A1 (en) * 2004-05-12 2005-11-16 Alcasynn Pharmaceuticals Gmbh Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
WO2015082932A1 (en) 2013-12-05 2015-06-11 The University Of Bath Novel opioid compounds and their uses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000995A1 (en) * 1987-07-29 1989-02-09 Regents Of The University Of Minnesota Delta opioid receptor antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3631829A1 (de) * 1986-09-19 1988-07-28 Hoechst Ag Klonierung und verwendung des transaminase gens-tyrb
JP2906654B2 (ja) * 1989-11-28 1999-06-21 東レ株式会社 免疫抑制剤及びその製造方法
JPH04342529A (ja) * 1991-05-21 1992-11-30 Toray Ind Inc 抗アレルギー剤
US5354863A (en) * 1992-01-21 1994-10-11 G. D. Searle & Co. Opioid agonist compounds
US5225417A (en) * 1992-01-21 1993-07-06 G. D. Searle & Co. Opioid agonist compounds
US5352680A (en) * 1992-07-15 1994-10-04 Regents Of The University Of Minnesota Delta opioid receptor antagonists to block opioid agonist tolerance and dependence
CN1043766C (zh) * 1992-09-29 1999-06-23 东丽株式会社 吲哚衍生物及其制法和它们在制备药物中的应用
US5457208A (en) * 1993-06-21 1995-10-10 Regents Of The University Of Minnesota Kappa opioid receptor antagonists
US5849731A (en) * 1995-09-26 1998-12-15 Toray Industries, Inc. Indole derivatives and medical application thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000995A1 (en) * 1987-07-29 1989-02-09 Regents Of The University Of Minnesota Delta opioid receptor antagonists

Also Published As

Publication number Publication date
NO941977L (no) 1994-07-29
FI942499A0 (fi) 1994-05-27
CA2124455C (en) 2004-09-14
US6087369A (en) 2000-07-11
AU672033B2 (en) 1996-09-19
WO1994007896A1 (fr) 1994-04-14
JP3605825B2 (ja) 2004-12-22
TW271440B (https=) 1996-03-01
EP0614898B1 (en) 2003-05-07
US6291470B1 (en) 2001-09-18
CA2124455A1 (en) 1994-04-14
CN1092425A (zh) 1994-09-21
FI942499L (fi) 1994-07-27
ES2199220T3 (es) 2004-02-16
KR100301093B1 (ko) 2001-10-22
NO941977D0 (no) 1994-05-27
DE69332945T2 (de) 2004-05-19
AU4834193A (en) 1994-04-26
FI942499A7 (fi) 1994-07-27
DE69332945D1 (de) 2003-06-12
EP0614898A1 (en) 1994-09-14
EP0614898A4 (en) 1994-10-12
ATE239732T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
CN1043766C (zh) 吲哚衍生物及其制法和它们在制备药物中的应用
CN1142910C (zh) 酰胺化合物
CN1290847C (zh) 氮杂－芳基哌嗪类化合物
CN1556705A (zh) 7,8,9,10-四氢-6H-氮杂卓并、6,7,8,9-四氢-吡啶并和2,3-二氢-2H-吡咯并[2,1-b]-喹唑啉酮衍生物
CN1072683A (zh) 水溶性喜树碱衍生物
CN1606545A (zh) 作为nk1拮抗剂的吡咯烷和哌啶衍生物
CN1072679A (zh) 吲哚衍生物
CN1665819A (zh) 吗啡喃衍生物及其14位取代季铵盐、制备方法和它们的用途
CN1239952A (zh) 用作nos抑制剂的6－苯基吡啶基－2－胺衍生物
CN1787818A (zh) 趋化因子受体活性的氨基环丁基酰胺调节剂
CN1946402A (zh) 用作ccr3拮抗剂的哌啶衍生物
CN1170395A (zh) 4a,5,9,10,11,12－六氢－6H－苯并呋喃并[3a,3,2－ef][2]苯并吖庚因衍生物的制备方法
CN1032438A (zh) 新的取代的n-(1-烷基-3-羟基-4-哌啶基)苯甲酰胺
CN1646528A (zh) 作为有效的α2－肾上腺素受体拮抗剂的多环化合物
CN1159303C (zh) 单环β-内酰胺类抗生素衍生物的中间体的制备方法
CN101048393A (zh) 作为γ－分泌酶抑制剂的取代的N－芳基磺酰基杂环胺
CN1157394C (zh) 二氢呋喃并[3,4-b]喹啉-1-酮类化合物、其制备方法和含有这些化合物的药物组合物
CN1031941C (zh) 氟代乙基喜树碱衍生物的制备方法
CN101080392A (zh) 作为抗肥胖药剂的哌嗪基吡啶衍生物
CN1027536C (zh) 4，5，6，7-四氢化苯并咪唑衍生物制备方法
CN1195757C (zh) 光学纯的喜树碱类似物及组合物和用途
CN1066449C (zh) 新的三环肟醚，其制备方法和含它们的药物组合物
CN1823059A (zh) 作为治疗肥胖和CNS疾病的选择性D<sub>1</sub>/D<sub>5</sub>受体拮抗剂的5－H－苯并[D]萘并[2,1－B]氮杂䓬衍生物
CN87106267A (zh) 新化合物2，3，4，5，6，7-六氢-2，7-亚甲基-1，5-苯并唑宁和-1，4-苯并唑宁，其制备方法及其药物组合物
CN1036197C (zh) 水溶性喜树碱衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee